• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算机筛选天然化合物作为候选 5HT6 受体拮抗剂治疗阿尔茨海默病。

In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer's Disease.

机构信息

Laboratory of Radiobiology and Molecular Genetics-080, Institute of Nuclear Sciences Vinca, National Institute of the Republic of Serbia, University of Belgrade, P.O. Box 522, 11000 Belgrade, Serbia.

Laboratory for Bioinformatics and Computational Chemistry, Institute of Nuclear Sciences Vinca, National Institute of the Republic of Serbia, University of Belgrade, P.O. Box 522, 11000 Belgrade, Serbia.

出版信息

Molecules. 2022 Apr 19;27(9):2626. doi: 10.3390/molecules27092626.

DOI:10.3390/molecules27092626
PMID:35565976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9101541/
Abstract

Alzheimer's disease (AD), a devastating neurodegenerative disease, is the focus of pharmacological research. One of the targets that attract the most attention for the potential therapy of AD is the serotonin 5HT6 receptor, which is the receptor situated exclusively in CNS on glutamatergic and GABAergic neurons. The neurochemical impact of this receptor supports the hypothesis about its role in cognitive, learning, and memory systems, which are of critical importance for AD. Natural products are a promising source of novel bioactive compounds with potential therapeutic potential as a 5HT6 receptor antagonist in the treatment of AD dementia. The ZINC-natural product database was in silico screened in order to find the candidate antagonists of 5-HT6 receptor against AD. A virtual screening protocol that includes both short-and long-range interactions between interacting molecules was employed. First, the EIIP/AQVN filter was applied for in silico screening of the ZINC database followed by 3D QSAR and molecular docking. Ten best candidate compounds were selected from the ZINC Natural Product database as potential 5HT6 Receptor antagonists and were proposed for further evaluation. The best candidate was evaluated by molecular dynamics simulations and free energy calculations.

摘要

阿尔茨海默病(AD)是一种破坏性的神经退行性疾病,是药物研究的重点。吸引最多注意力用于 AD 潜在治疗的靶点之一是 5-羟色胺 5HT6 受体,它是唯一位于中枢神经系统的谷氨酸能和 GABA 能神经元上的受体。该受体的神经化学影响支持了其在认知、学习和记忆系统中的作用的假说,这些系统对 AD 至关重要。天然产物是具有潜在治疗潜力的新型生物活性化合物的有希望的来源,可作为治疗 AD 痴呆的 5HT6 受体拮抗剂。对 ZINC 天然产物数据库进行了计算机筛选,以寻找针对 AD 的 5-HT6 受体的候选拮抗剂。采用了一种包括相互作用分子之间短程和远程相互作用的虚拟筛选方案。首先,应用 EIIP/AQVN 过滤器对 ZINC 数据库进行计算机筛选,然后进行 3D-QSAR 和分子对接。从 ZINC 天然产物数据库中选择了十个最佳候选化合物作为潜在的 5HT6 受体拮抗剂,并提出进一步评估。通过分子动力学模拟和自由能计算评估了最佳候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5378/9101541/dfb08b8188f0/molecules-27-02626-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5378/9101541/1d323eadece2/molecules-27-02626-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5378/9101541/e506af2d3c73/molecules-27-02626-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5378/9101541/d578a9b8fa6b/molecules-27-02626-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5378/9101541/c90a3bb259fe/molecules-27-02626-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5378/9101541/95bd608f7425/molecules-27-02626-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5378/9101541/93069f413405/molecules-27-02626-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5378/9101541/dfb08b8188f0/molecules-27-02626-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5378/9101541/1d323eadece2/molecules-27-02626-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5378/9101541/e506af2d3c73/molecules-27-02626-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5378/9101541/d578a9b8fa6b/molecules-27-02626-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5378/9101541/c90a3bb259fe/molecules-27-02626-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5378/9101541/95bd608f7425/molecules-27-02626-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5378/9101541/93069f413405/molecules-27-02626-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5378/9101541/dfb08b8188f0/molecules-27-02626-g007.jpg

相似文献

1
In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer's Disease.计算机筛选天然化合物作为候选 5HT6 受体拮抗剂治疗阿尔茨海默病。
Molecules. 2022 Apr 19;27(9):2626. doi: 10.3390/molecules27092626.
2
Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease.针对阿尔茨海默病的环依赖性激酶 5 进行小分子天然产物的虚拟筛选、药代动力学、分子动力学和结合自由能分析。
J Biomol Struct Dyn. 2020 Jan;38(1):248-262. doi: 10.1080/07391102.2019.1571947. Epub 2019 Feb 21.
3
Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach.鉴定针对阿尔茨海默病的多靶标导向配体的天然化合物:一种计算方法。
J Biomol Struct Dyn. 2019 Mar;37(5):1282-1306. doi: 10.1080/07391102.2018.1456975. Epub 2018 Apr 23.
4
Design, ADMET Screening, Prime MM-GBSA Binding Free Energy Calculation and MD Simulation of Some Novel Phenothiazines as 5HTR Antagonists Targeting Alzheimer's Disease.一些新型吩噻嗪作为靶向阿尔茨海默病的5HTR拮抗剂的设计、ADMET筛选、Prime MM-GBSA结合自由能计算及分子动力学模拟
Curr Comput Aided Drug Des. 2025;21(4):487-502. doi: 10.2174/0115734099282836231212064925.
5
Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV.基于分子对接、QSAR 和 ADMET 的 HIV 主要靶标天然化合物挖掘。
J Biomol Struct Dyn. 2019 Jan;37(1):131-146. doi: 10.1080/07391102.2017.1420489. Epub 2018 Jan 7.
6
Machine Learning, Molecular Modeling, and QSAR Studies on Natural Products Against Alzheimer's Disease.基于机器学习、分子建模和定量构效关系研究天然产物抗老年痴呆症。
Curr Med Chem. 2021;28(38):7808-7829. doi: 10.2174/0929867328666210603104749.
7
Predicting biological activity and design of 5-HT antagonists through assessment of ANN-QSAR models in the context of Alzheimer's disease.通过评估人工神经网络定量构效关系模型在阿尔茨海默病背景下的生物活性和设计 5-HT 拮抗剂。
J Mol Model. 2024 Sep 26;30(10):350. doi: 10.1007/s00894-024-06134-5.
8
Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.通过药效团、基于原子的定量构效关系、对接和分子动力学模拟对长春花结构域微管蛋白结合剂进行结构研究。
Comb Chem High Throughput Screen. 2017;20(8):682-695. doi: 10.2174/1386207320666170509151253.
9
Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.通过基于药效团的设计、3D-QSAR 和针对阿尔茨海默病的分子动力学模拟来鉴定潜在的蛋白激酶 C 抑制剂。
J Biomol Struct Dyn. 2018 Nov;36(15):4029-4044. doi: 10.1080/07391102.2017.1406824. Epub 2017 Dec 13.
10
Natural Products based P-glycoprotein Activators for Improved β-amyloid Clearance in Alzheimer's Disease: An in silico Approach.基于天然产物的P-糖蛋白激活剂用于改善阿尔茨海默病中的β-淀粉样蛋白清除:一种计算机模拟方法。
Cent Nerv Syst Agents Med Chem. 2015;16(1):50-9. doi: 10.2174/1871524915666150826092152.

引用本文的文献

1
Novel 5-HTR modulators as mTOR-dependent neuronal autophagy inductors.新型5-羟色胺受体(5-HTR)调节剂作为mTOR依赖性神经元自噬诱导剂。
Sci Rep. 2025 Mar 11;15(1):8380. doi: 10.1038/s41598-025-92755-6.
2
Targeting serotonin receptors with phytochemicals - an in-silico study.利用植物化学物质靶向血清素受体——一项计算机模拟研究。
Sci Rep. 2024 Dec 5;14(1):30307. doi: 10.1038/s41598-024-76329-6.
3
In Silico Investigation of Selected Pesticides and Their Determination in Agricultural Products Using QuEChERS Methodology and HPLC-DAD.

本文引用的文献

1
The Phenoxyalkyltriazine Antagonists for 5-HT Receptor with Promising Procognitive and Pharmacokinetic Properties In Vivo in Search for a Novel Therapeutic Approach to Dementia Diseases.具有体内促认知和药代动力学特性的苯氧烷基三嗪 5-HT 受体拮抗剂,寻找治疗痴呆症的新方法。
Int J Mol Sci. 2021 Oct 5;22(19):10773. doi: 10.3390/ijms221910773.
2
Safety, Tolerability and Pharmacokinetics of the Serotonin 5-HT6 Receptor Antagonist, HEC30654, in Healthy Chinese Subjects.5-羟色胺5-HT6受体拮抗剂HEC30654在健康中国受试者中的安全性、耐受性及药代动力学
Front Pharmacol. 2021 Aug 19;12:726536. doi: 10.3389/fphar.2021.726536. eCollection 2021.
3
采用 QuEChERS 方法和 HPLC-DAD 对选定农药及其在农产品中的测定进行计算机模拟研究。
Int J Mol Sci. 2023 Apr 28;24(9):8003. doi: 10.3390/ijms24098003.
4
Novel Thiosemicarbazone Quantum Dots in the Treatment of Alzheimer's Disease Combining In Silico Models Using Fingerprints and Physicochemical Descriptors.新型硫代氨基脲量子点结合使用指纹图谱和物理化学描述符的计算机模拟模型治疗阿尔茨海默病
ACS Omega. 2023 Mar 17;8(12):11076-11099. doi: 10.1021/acsomega.2c07934. eCollection 2023 Mar 28.
Chemical update on the potential for serotonin 5-HT and 5-HT receptor agents in the treatment of Alzheimer's disease.
血清素5-HT及5-HT受体药物治疗阿尔茨海默病潜力的化学进展
Bioorg Med Chem Lett. 2021 Oct 1;49:128275. doi: 10.1016/j.bmcl.2021.128275. Epub 2021 Jul 23.
4
AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings.AutoDock Vina 1.2.0:新的对接方法、扩展的力场及Python绑定
J Chem Inf Model. 2021 Aug 23;61(8):3891-3898. doi: 10.1021/acs.jcim.1c00203. Epub 2021 Jul 19.
5
Intepirdine as adjunctive therapy to donepezil for mild-to-moderate Alzheimer's disease: A randomized, placebo-controlled, phase 3 clinical trial (MINDSET).安奈吡啶作为多奈哌齐治疗轻至中度阿尔茨海默病的辅助疗法:一项随机、安慰剂对照的3期临床试验(MINDSET)。
Alzheimers Dement (N Y). 2021 May 31;7(1):e12136. doi: 10.1002/trc2.12136. eCollection 2021.
6
NPBS database: a chemical data resource with relational data between natural products and biological sources.NPBS 数据库:一个包含天然产物和生物源之间关系型数据的化学数据资源。
Database (Oxford). 2020 Dec 11;2020. doi: 10.1093/database/baaa102.
7
Serotonin research: Crossing scales and boundaries.血清素研究:跨越尺度和边界。
Neuropharmacology. 2020 Dec 15;181:108340. doi: 10.1016/j.neuropharm.2020.108340. Epub 2020 Sep 30.
8
Boosting Free-Energy Perturbation Calculations with GPU-Accelerated NAMD.利用GPU加速的NAMD增强自由能微扰计算
J Chem Inf Model. 2020 Nov 23;60(11):5301-5307. doi: 10.1021/acs.jcim.0c00745. Epub 2020 Sep 1.
9
G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits.中枢神经系统中的 G 蛋白偶联受体:干预神经退行性疾病和相关认知缺陷的潜在治疗靶点。
Cells. 2020 Feb 23;9(2):506. doi: 10.3390/cells9020506.
10
Clinical trials of new drugs for Alzheimer disease.治疗阿尔茨海默病新药的临床试验。
J Biomed Sci. 2020 Jan 6;27(1):18. doi: 10.1186/s12929-019-0609-7.